logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
M

Meredith M. Regan

dana-farber cancer institute

95H-index
675Paper Count
4.2WCitation Count
Published Papers 225
Publication Date
logo
Now or later? Switching therapies in metastatic breast cancer
errLancet Oncology
IF35.9
err2026-07-13
err0
PREAI
errCarmine Valenza; Meredith M Regan; Harold J Burstein
errShare
errSave
Identifying Premenopausal Patients with Early-Stage Hormone Receptor–Positive Breast Cancer at Minimal Risk of Distant Recurrence by Breast Cancer Index
errThe Breast
IF0
err2026-01-29
err0
errOAAI
errRuth M. O’Regan; Yue Ren; Yi Zhang; Gini F. Fleming; Prudence A. Francis; Olivia Pagani; Barbara A. Walley; Roswitha Kammler; Patrizia Dell’Orto; Giuseppe Viale; Sherene Loi; Marco Colleoni; Kai Treuner; Meredith M. Regan
errShare
errSave
Optimizing adjuvant endocrine therapy in premenopausal patients with HER2-positive, hormone receptor-positive breast cancer
errThe Breast
IF0
err2026-01-12
err0
errOAAI
errCarmine Valenza; Ann H. Partridge; Meredith M. Regan
errShare
errSave
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database
errBreast Cancer Research and Treatment
IF3
err2025-12-24
err0
PREAI
errPietro De Placido; Elizabeth Troll; Samuel M. Niman; Sean Ryan; Ginny Mason; Mariesa Powell; Aditi Hazra; Nikhil Wagle; Mary McGillicuddy; Nancy U. Lin; Sara M. Tolaney; Faina Nakhlis; Meredith M. Regan; Filipa Lynce
errShare
errSave
Tailoring Treatment to Cancer Risk and Patient Preference: The 2025 St Gallen International Breast Cancer Consensus Statement on Individualizing Therapy for Patients With Early Breast Cancer
errAnnals of Oncology
IF65.4
err2025-10-08
err0
errOAAI
errH.J. Burstein; G. Curigliano; M. Gnant; S. Loibl; M.M. Regan; S. Loi; C. Denkert; P. Poortmans; D. Cameron; B. Thurlimann; W.P. Weber
errShare
errSave
Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study
errBreast Cancer Research
IF5.6
err2025-10-03
err0
errOAAI
errKristina Fanucci; Eren D. Yeh; Ruichao Shi; Lei Qin; Camden P. Bay; Molly DiLullo; Ashka Patel; McKenna Moore; Zachary T. Herbert; Beth T. Harrison; Faina Nakhlis; Jennifer Bellon; Laura Warren; Jennifer L. Guerriero; Sara M. Tolaney; Meredith Regan; Beth Overmoyer; Steven Van Laere; Filipa Lynce
errShare
errSave
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT
errCancer
IF5.1
err2025-09-23
err0
PREAI
errKarin Ribi PhD; Bernard F. Cole PhD; Gini F. Fleming MD; Barbara A. Walley MD; Prudence A. Francis MD; Ehtesham Abdi MD; Harold J. Burstein MD, PhD; Kit L. Cheng MD; Stephen K. L. Chia MD, FRCP; Shaker R. Dakhil MD; Nancy E. Davidson MD; Stephen A. Della-Fiorentina MD; Ashley E. Frith MD; Ellis Levine MD; Sasha Lupichuk MD; Kathleen Pritchard MD; Muhammad Salim MD; Vered Stearns MD; Josephine Stewart MD; Vicente Valero MD; Andre van der Westhuizen MD; Olivia Pagani MD; Sherene Loi MD, PhD; Marco Colleoni MD; Richard D. Gelber PhD; Aron Goldhirsch MD; Alan S. Coates MD; Meredith M. Regan ScD; Jürg Bernhard PhD
errShare
errSave
The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials
errJNCI CANCER SPECTRUM
IF4.1
err2025-08-01
err0
errOAAI
errChang, Elaine; Gittleman, Haley; Song, Chi; Bloomquist, Erik; Fernandes, Laura; Weinstock, Chana; Agrawal, Sundeep; Gormley, Nicole; Tang, Shenghui; Suzman, Daniel L.; Amiri-Kordestani, Laleh; Pazdur, Richard; Kluetz, Paul G.; McDermott, David F.; Regan, Meredith M.; Rini, Brian, I
errShare
errSave
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer☆
errESMO Open
IF8.3
err2025-07-25
err0
errOAAI
errR. Jeselsohn; J. Fu; Y. Ren; R. Mahtani; C. Ma; A. DeMichele; M. Cristofanilli; J. Meisel; K.D. Miller; Y. Abdou; E.C. Riley; R. Qamar; P. Sharma; S. Reid; N. Ko; Y. Liu; E. Gauthier; H.J. Burstein; M. DeMeo; M. Regan; S.M. Tolaney; E.L. Mayer
errShare
errSave
Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic NSCLC Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1
errJournal of Thoracic Oncology
IF20.8
err2025-06-03
err0
PREAI
errSolange Peters; Meredith M. Regan; Luis G. Paz-Ares; Martin Reck; Hossein Borghaei; Kenneth J. O’Byrne; Julie R. Brahmer; John R. Penrod; Janice Li; LaRee Tracy; Yong Yuan; Judith Bushong; Adam Lee; Laura J. Eccles; Saurabh Ray; Suresh S. Ramalingam
errShare
errSave
Development of a multi-institutional dataset to validate a novel inflammatory breast cancer diagnostic score
errJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
err2025-03-31
err0
PREAI
errLynce, Filipa; Niman, Samuel M.; Kai, Megumi; Ryan, Sean; Troll, Elizabeth; Li, Li; Miller, Kathy D.; Jagsi, Reshma; Mason, Ginny; Overmoyer, Beth A.; Le-Petross, H. T. Carisa; Nakhlis, Faina; Krishnamurthy, Savitri; Harrison, Beth T.; Sun, Susie X.; Yeh, Eren D.; Bellon, Jennifer R.; Warren, Laura E.; Stauder, Michael C.; Regan, Meredith M.; Woodward, Wendy A.
errShare
errSave
Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2025-02-01
err1
PREAI
errGupta, Mehul; Wells, Connor; Regan, Meredith M.; Xie, Wanling; Navani, Vishal; Saliby, Renee Maria; Basa, Naveen S.; Donskov, Frede; Yuasa, Takeshi; Takemura, Kosuke; Kollmannsberger, Christian K.; Crumbaker, Megan; Lalani, Aly-Khan A.; Powles, Thomas; Ebrahimi, Hedyeh; Mckay, Rana R.; Lee, Jae-Lyun; Kanesvaran, Ravindran; Choueiri, Toni K.; Heng, Daniel Y. C.
errShare
errSave
Pathological complete response with chemotherapy and immune checkpoint inhibition in triple negative inflammatory breast cancer (TN-IBC)
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errLynce, Filipa; Niman, Samuel; Goncalves, Anthony; Kai, Megumi; Ryan, Sean; Troll, Elizabeth; Layman, Rachel; Giordano, Antonio; Nasrazadani, Azadeh; Nakhlis, Faina; Bellon, Jennifer; Warren, Laura; Block, Caroline; Schumer, Susan; Lucci, Anthony; Krishnamurthy, Savitri; Lerebours, Florence; Dalenc, Florence; Levy, Christelle; Petit, Thierry; Leheurteur, Marianne; Bachelot, Thomas; Tredan, Olivier; Ladoire, Sylvain; Almeida, Leonor Lopez; Zemmour, Christophe; Tolaney, Sara; Valero, Vicente; Bertucci, Francois; Regan, Meredith; Woodward, Wendy
errShare
errSave
Development of a multi-institutional, photograph-rich clinical dataset to test and validate a novel inflammatory breast cancer (IBC) scoring system
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errLynce, Filipa; Niman, Samuel; Kai, Megumi; Ryan, Sean; Troll, Elizabeth; Li, Li; Miller, Kathy; Jagsi, Reshma; Mason, Ginny; Overmoyer, Beth; Le-Petross, H. T. Carisa; Nakhlis, Faina; Krishnamurthy, Savitri; Harrison, Beth; Sun, Susie X.; Yeh, Eren; Bellon, Jennifer; Warren, Laura; Stauder, Michael; Regan, Meredith; Woodward, Wendy
errShare
errSave
Genomic and intrinsic subtype correlates of serum thymidine kinase activity in patients with metastatic breast cancer treated with palbociclib and fulvestrant in the PYTHIA trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errTyekucheva, Svitlana; Crestani, Thayane; Ignatiadis, Michail; Neven, Patrick; Colleoni, Marco; Henry, Stephanie; Papadimitriou, Konstantinos; Bernardo, Antonio; Seles, Elena; Duhoux, Francois; Macpherson, Iain; Thomson, Alastair; Davies, David Mark; Bergqvist, Mattias; Migliaccio, Ilenia; Zoppoli, Gabriele; Kammler, Roswitha; De Swert, Heidi; Ruepp, Barbara; Guerrero, Angel; Llinas, Arnau; Fimereli, Danai; Arahmani, Amal; Cameron, David; Loi, Sherene; Piccart, Martine; Regan, Meredith; Benelli, Matteo; Malorni, Luca
errShare
errSave
TRUDI: A phase II study of neoadjuvant TRastuzumab derUxtecan and Durvalumab for stage III HER2expressing Inflammatory breast cancer
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errTarantino, Paolo; Niman, Samuel; Giordano, Antonio; Nakhlis, Faina; Bellon, Jennifer; Woodward, Wendy; Nasrazadani, Azadeh; Saleem, Sadia; Lucci, Anthony; DeMeo, Michelle; Ueno, Naoto; Tolaney, Sara; Valero, Vicente; Regan, Meredith; Layman, Rachel; Lynce, Filipa
errShare
errSave
RBsig geneexpression signature in patients with endocrine resistant metastatic breast cancer treated with palbociclib and fulvestrant in the PYTHIA trial
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errBenelli, Matteo; Tyekucheva, Svitlana; Crestani, Thayane; Ignatiadis, Michail; Neven, Patrick; Colleoni, Marco; Henry, Stephanie; Papadimitriou, Konstantinos; Bernardo, Antonio; Seles, Elena; Duhoux, Francois; Macpherson, Iain; Thomson, Alastair; Davies, David Mark; Migliaccio, Ilenia; Zoppoli, Gabriele; Kammler, Roswitha; De Swert, Heidi; Ruepp, Barbara; Aftimos, Philippe; Seoane, Jose; Romagnoli, Dario; Venet, David; Goulioti, Theodora; Cameron, David; Loi, Sherene; Piccart, Martine; Regan, Meredith; Malorni, Luca
errShare
errSave
AVIATOR/ TBCRC045: A randomized phase II study of vinorelbine (N) plus trastuzumab (H) alone or combined with avelumab (A) plus /- utomilumab (U) in patients (pts) with HER2+metastatic breast cancer (MBC) (NCT03414658)
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errWaks, Adrienne; Shi, Ruichao; Regan, Meredith; Dang, Chau; Santa-Maria, Cesar; Westbrook, Kelly; Abramson, Vandana; Murthy, Rashmi; Nanda, Rita; Rugo, Hope; Clark, Amy; Mainor, Candace; Dees, Claire; Hoyos, Valentina; Miller, Kathy; Stringer-Reasor, Erica; Hunter, Natasha; Oh, Sun Young; Demeo, Michelle; Okpoebo, Amanda; Elias, Erin; Kurt, Busem; Lin, Nancy; Rimawi, Mothaffar; Wolff, Antonio; Mittendorf, Elizabeth; Goel, Shom; Tolaney, Sara; Loi, Sherene; Krop, Ian
errShare
errSave
Randomized Phase II Study of Neoadjuvant Nivolumab (N) 2 week lead-in followed by 12 weeks of concurrent N plus carboplatin plus paclitaxel (CbP) vs concurrent N plus CbP in Triple Negative Breast Cancer (TNBC): (BCT1902/IBCSG 61-20 Neo-N)
errCANCER RESEARCH
IF16.6
err2024-05-02
err1
PREAI
errLoi, Sherene; Niman, Samuel; Zdenkowski, Nicholas; Francis, Prudence; Hay, Sally Baron; Fox, William; Punie, Kevin; Menzies, Alexander M.; Angus, Rebecca; Mavin, Carlie; Rennie, Lauren; Stoodley, Isobel; Mann, Bruce; Kuper-Hommel, Marion Jj; Regan, Meredith
errShare
errSave
Protocol-defined biomarker analysis in the PALLAS (AFT-05) adjuvant trial: Genomic subtype derived from RNA sequencing of HR+/HER2-early breast cancer
errCANCER RESEARCH
IF16.6
err2024-05-02
err0
PREAI
errStover, Daniel; Hlauschek, Dominik; Mayer, Erica; Symmans, W. Fraser; Watson, Mark; Barozzi, Iros; Filipits, Martin; Ballman, Karla; Bellet-Ezquerra, Meritxell; Balko, Justin; Rubovszky, Gabor; Zdenkowski, Nicholas; Brufsky, Adam; Steger, Guenther; Isaacs, Claudine; Loibl, Sibylle; Henao, Fernando; Regan, Meredith; Liu, Yuan; Fesl, Christian; O'Brien, Patrick; DeMichele, Angela; Gnant, Michael; Metzger, Otto
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
E
Eric P. Winer
H-index: 170 · Papers: 1.6K
G
Giuseppe Viale
H-index: 157 · Papers: 1.3K
M
Martine Piccart
H-index: 149 · Papers: 1.6K
T
Toni K. Choueiri
H-index: 149 · Papers: 2.4K
View more